Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Avastin in combination with Herceptin and docetaxel in HER2-positive metastatic breast cancer has completed, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• DOCETAXEL (DOCETAXEL)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-08-14